• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Evgen Pharma: Johns Hopkins research further assesses the potential of company’s drug to treat COVID-19

steve | 7 April 2021
Categories: Media Coverage

Post navigation

← Going for Growth: Evgen Pharma CEO, Huw Jones, interviewed by ShareBuyers
Evgen Pharma makes progress on two fronts in the field of cancer →
Copyright© 2023
  • Privacy Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch